Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Sep. 12, 2016

Celyad completes phase I trial of NKR-2 T-cell therapy

Sep. 9, 2016

BioLineRx and Genentech to investigate atezolizumab plus BL-8040 in oncology indications

Sep. 9, 2016

FDA grants priority review to sBLA for Keytruda as first-line treatment for NSCLC

Sep. 8, 2016

First patients enrolled in Jounce Therapeutics' ICONIC study

Sep. 8, 2016

Opdivo intravenous infusion approved in Japan for treatment of unresectable or metastatic RCC

Sep. 8, 2016

131-I-8H9 monoclonal antibody granted FDA orphan drug designation in neuroblastoma

Sep. 6, 2016

Genentech reports positive results from phase III OAK study of atezolizumab

Sep. 5, 2016

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical generate anti-HER2 antibody-drug conjugate

Sep. 5, 2016

Amgen obtains global rights to BI-836908 from Boehringer Ingelheim

Sep. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...